The Trump Administration is considering limiting approval for COVID-19 boosters to seniors and others at high risk, including ...

Belite Bio recently announced the US Food and Drug Administration (FDA) granted Breakthrough Therapy Designation for the ...

Poison hemlock has spread throughout the US. Here's how to kill it. Missouri family finds a DIY solution to expensive storm shelters The Cybertruck's First Real Test - And It Didn't Go Well Ketanji ...

Apellis Pharmaceuticals focuses on creating medicines targeting eye diseases and rare neurological diseases. Read why I rate ...

Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...

The product, manufactured by Bowman Andros LLC and distributed exclusively to Publix stores, was sold in 4-ounce plastic ...

The Texas Department of State Health Services (TDSHS) today reported four more measles cases since its last update on May 16 ...

Tinlarebant has previously been granted Fast Track and Rare Pediatric Disease Designations in the U.S., Orphan Drug ...

Lecia Eubanks won the LaFayette Woman’s Club’s 2025 Club Appreciation Award, as the Woman's Club and the LaFayette Juniorette ...

Astellas has shored up the competitive profile of Izervay as a treatment for eye disorder geographic atrophy (GA), getting FDA approval for an extended treatment duration. The US regulator turned ...

GA affects an estimated 1.5 million people in ... "We are thrilled to receive FDA approval of Izervay and to offer a new therapy to physicians and appropriate patients in the US," said Pravin ...